The clinical usefulness of ^99mTc-Tetrofosmin scintigraphy in the diagnosis of lung neoplasmas and mediastinal lymphoid node involvement

Abstract

In order to investigate the clinical significance of ^99mTc-Tetrofosmin (TF) scintigraphy in the evaluation of lung cancer and mediastinal lymphoid node involvement, 33 patients with pulmonary neoplasmas were subjected to both ^99mTc-TF scintigraphies and CT scans in one week before their operations or puncturations. All the images were judged visually and the emission images were analyzed with semi-quantitative methods in addition. The results of each group were compared. There was marked difference in target/non-target (T/N) ratio between the lung cancer group and the benign lesion group (P<0.001). Moreover, in the lung cancer group, T/N ratio in tomographies was significantly higher than that in planar images (P<0.01). The sensitivity and accuracy of semi-quantitative analysis in ^99mTc-TF SPECT were significantly higher than those of CT in the diagnosis of pulmonary neoplasmas (P<0.05 and P<0.01 respectively), so was the sensitivity of ^99mTc-TF SPECT vs CT in the diagnosis of mediastinal lymphoid node metastasis (P<0.05). It was also found that epidermoid squamous cell carcinomas and adenocarcinomas had a higher T/N ratio than in small cell carcinomas (P<0.05), and 2 h washout rate (WR) of adenocarcinomas was higher than that of epidermoid squamous cell carcinomas (P<0.05). In conclusion, ^99mTc-TF scintigraphy showed a favorable diagnostic accuracy in appraising lung cancers and mediastinal lymph node metastases. Furthermore semi-quantitative technology can improve the accuracy, and is potential to offer some information about histological type of the cancer tissue. Therefore, ^99mTc-TF scintigraphy will be a useful tool in the diagnosis and staging of lung cancer.

Keywords

lung neoplasm / mediastinum / lymph node / ^99mTc-Tetrofosmin / scintigraphy

References

[1] SukanA., YaparZ., SAhinB., et al.. ^99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response. Nucl Med Commun, 2004, 25(8): 777-785

[2] FattoriB., GrossoM., NacciA., et al.. The role of ^99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer. Cancer Biother Radiopharm, 2005, 20(1): 27-35

[3] FilippiL., SchillaciO., SantoniR., et al.. Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc-99m] tetrofosmin. Cancer Biother Radiopharm, 2006, 21(1): 41-48

[4] JaukovicL. D. J., AjdinovicB. Z., JankovicZ. D., et al.. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement. Nucl Med Rev Cent East Eur, 2006, 9(1): 30-36

[5] ArbabA. S., KoizumiK., AraiT., et al.. Application of Tc-99m-TF as a tumor imaging agent: comparison with Tl-201. Ann Nucl Med, 1996, 10(2): 271-274

[6] NosottiM., SantambrogioL., GaspariniM., et al.. Role of ^99mTc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer. Chest, 2002, 122(4): 1361-1364

[7] YamamotoY., NishiyamaY., SatohK., et al.. Comparative evaluation of Tc-99m MIBI and Tl-201 chloride SPECT in non-small-cell lung cancer mediastinal lymph node metastases. Clin Nucl Med, 2000, 25(1): 29-32

[8] MinaiO. A., RajaS., MehtaA. C., et al.. Role of Tc-99m MIBI in the evaluation of single pulmonary nodules: a preliminary report. Thorax, 2000, 55(1): 60-68

[9] KomoriT., NarabayashiI., MatsuiR., et al.. Evaluation of uptake and release of technetium-99m MIBI SPECT of pulmonary and mediastinal lesions. Ann Nucl Med, 1997, 11(3): 227-232

[10] FukumotoM., YoshidaD., HayaseN., et al.. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma. Cancer, 1999, 86(8): 1470-1479

[11] KaoC. H., HsiehJ. F., TsaiS. C., et al.. Paclitaxel-based chemotherapy for non-small cell lung cancer: predicting the response with ^99mTc-tetrofosmin chest imaging. J Nucl Med, 2001, 42(1): 17-20